NLRP3 and colorectal carcinoma: In summary, our results identified NLRP3 as an integral functional target of HDAC2 and substantiated the NLRP3 pathway, in which HDAC2 governs pharmacological pyroptosis in colorectal carcinoma by modulating NLRP3 levels.